← All organizations
Highest phase reached
Phase 2
First clinical trial
Jan 1, 2018Last known activity
Nov 17, 2022
Timeline
2010s
- Jan 1, 2018
James and Esther King Biomedical Research Program— Founded
Drugs by trial phase (12 distinct, 9 trials)
Phase 2 (9 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT05645146CollaboratorN/ANov 17, 2022
- NCT03598309CollaboratorPhase 2Nov 30, 2018
- NCT03370276CollaboratorPhase 1/Phase 2Dec 6, 2017
- NCT02796391CollaboratorPhase 2Sep 30, 2017
- NCT02585791CollaboratorN/ASep 1, 2016
- NCT02461706CollaboratorN/AJun 1, 2015
- NCT02202499CollaboratorEarly Phase 1Jul 17, 2014
- NCT01433172CollaboratorPhase 1/Phase 2Oct 1, 2012
- NCT01625260CollaboratorPhase 1/Phase 2Apr 1, 2012
Details
- Founded
- Tallahassee, FL, US Jan 1, 2018
- Last known activity
- Nov 17, 2022